CAMBRIDGE, Mass., May 22, 2013 /PRNewswire via COMTEX/ -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics(TM), a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that John Reynders will join Moderna in early July as its first Chief Information Officer.

Dr. Olson's Extensive Experience in Personalized Medicine Will Support Syros' Mission to Lead in Gene Control

CAMBRIDGE, Mass., May 22, 2013 /PRNewswire/ -- Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Stephane Bancel as a Senior Partner. In this role, Mr. Bancel will provide strategic counsel and support to portfolio companies.

WATERTOWN, Mass.--(BUSINESS WIRE)--

Tetraphase Pharmaceuticals, Inc. (TTPH) today reported financial results for the first quarter ended March 31, 2013.

SysDx helps doctors make the best therapeutic decisions by providing an in-depth understanding of intervening biochemical mechanisms

Waltham-Based Software and Services Provider Recognized as One of the Most Innovative Companies in New England

WALTHAM, Mass., May 10, 2013 (BUSINESS WIRE) -- Affinnova, Inc., a global provider of software and services used by companies to dramatically improve their innovation and marketing success rates, today announced that it has won the New England Innovation Award, sponsored by the Small Business Association of New England (SBANE).

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

LEXINGTON, Mass.--(BUSINESS WIRE)--